Vascular smooth muscle cell (VSMC) proliferation and migration are pivotal for the pathogenesis of atherosclerosis and post-angioplasty restenosis. We have recently reported that a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7), a novel metalloproteinase, contributes directly to neointima formation by mediating VSMC migration. However, whether ADAMTS-7 affects VSMC proliferation remains unclear. In this study, we found that luminal adenoviral delivery of ADAMTS-7 aggravated intimal hyperplasia 7 d after injury, paralleled by an increased percentage of PCNA-positive cells in both intima and media. In contrast, perivascular administration of ADAMTS-7 siRNA, but not scrambled siRNA to injured arteries attenuated intimal thickening at day 7, paralleled with reduced intimal VSMC replication, without alteration of VSMC proliferation in the media. In accordance, [
Abnormal vascular smooth muscle cell (VSMC) proliferation has been recognized as a predominant mechanism accounting for atherosclerosis and restenosis after angioplasty [1, 2] . In healthy mature blood vessels, VSMCs exhibit a contractile phenotype, surrounded by and embedded in an extracellular matrix (ECM) scaffold, and exhibit extremely low rates of proliferation. Upon environmental stimulation such as injury, growth factors or chemokines, VSMCs in the media are converted to a synthetic phenotype and then migrate to the intima where they undergo proliferation [3, 4] .
As a part of this process, the extracellular matrix proteins that normally surround the cells in the media and the interstitial matrix must be reorganized. Accordingly, matrix-degrading proteases have been proposed to function in modulating VSMCs migration and proliferation [5, 6] . Previous studies have emphasized potential roles for the matrix metalloproteinases (MMPs) MMP-2, MMP-9 and MT1-MMP, the serine proteinases, plasminogen activator and plasminogen, the cysteine proteinases, cathepsins K, L, S, etc. during matrix remodeling and VSMC migration [7] . Others have demonstrated that MMPs also affect VSMC proliferation via growth factors mobilization or N-cadherin shedding and subsequent β-catenin signaling [8] . However, the identification of the key proteinases during pathological vascular remodeling in vivo has remained the subject of speculation.
Recently, using a balloon-injured rat carotid artery model, we have identified the importance of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7), a novel ADAMTS family proteinase, in mediation of VSMC migration and promoting neointima formation following artery injury through degradation of cartilage oligomeric matrix protein (COMP) [911] . Moreover, ADAMTS-7 promotes VSMC and aortic calcification by disturbing the balance between osteogenic BMP-2 and its natural inhibitor COMP [12, 13] . Three recent genome-wide association studies (GWASs) have revealed ADAMTS7 as a novel locus associated with human coronary atherosclerosis [1416] . Further study uncovers a non-synonymous single nucleotide polymorphism (SNP) in the prodomain of ADAMTS-7 that is inversely related to VSMC migration, COMP cleavage and the prevalence of atherosclerosis [17] . However, whether ADAMTS-7 increases neointima formation by promoting VSMC proliferation remains unknown. In the current study, we demonstrated for the first time that ADAMTS-7 facilitates VSMC proliferation both in vitro and in vivo.
Materials and methods

Animal artery injury
All studies followed the guidelines of the Animal Care and Use Committee of Peking University. Male SpragueDawley rats (210230 g) were used in all experiments for the carotid artery ballon-injury model. Briefly, a balloon catheter of 1.5-mm diameter (Medtronic, Minneapolis, MN, USA) was introduced through the left external carotid artery and advanced about 4 cm toward the thoracic aorta. The balloon was distended with gas and then pulled back to the bifurcation with constant rotation. This procedure was repeated three times to ensure complete endothelial denudation. Contralateral carotid arteries underwent a similar operation without injury and served as sham controls.
VSMC isolation and culture
VSMCs were isolated from the thoracic aortic arteries of 150180 g male Sprague-Dawley rats by collagenase digestion as described previously [10] . Cells from passages 4 to 8 were used in all experiments.
Recombinant adenovirus construction
The adenovirus expressing ADAMTS-7 (Ad-ADAMTS-7) was constructed and amplified according to the manufacturer's protocol (BD Biosciences Clontech, CA, USA). An adenovirus expressing green fluorescence protein (Ad-GFP) was served as a negative control. For in vivo infection, immediately after balloon injury, a single exposure of 5×10 8 plaque forming units (pfu) of Ad-ADMSTS-7 was luminal delivered to injured carotid segments and remained for 30 min for sufficient infection. Then, the adenovirus solution was removed and blood flow was restored.
ADAMTS-7 siRNA transfection
ADAMTS-7 siRNA (siRNA ADAMTS-7 ) was designed using the Block-iT RNAi Designer and chemically modified by the manufacturer (Stealth siRNAs, Invitrogen, USA). Sequences corresponding to the siRNA ADAMTS-7 were: sense, 5-CACA-UCACCGUUGUGCGCCUUAUUA-3; and antisense, 5-UAAUAAGGCGCACAACGGUGAUGUG-3. A scrambled Stealth RNAi duplex (catalog No. 12935, Invitrogen) was served as a negative control. For in vivo studies, 15 μg of siRNA dissolved in 30% pluronic gel solution was perivascular delivered to the rat carotid arteries immediately after balloon-injury. For in vitro studies, transfection of rat primary VSMCs with the siRNA (50 nmol L 1 ) was performed using Oligofectamine (Invitrogen).
Western blot analysis
Rat artery extracts or VSMCs lysates containing equal amounts of total protein (60 μg) were resolved by 10% SDS-PAGE. The membranes were incubated with primary antibody followed by IRDye 700DX-conjugated secondary antibody (Rockland Inc, Gilbertsville, PA, USA). The immunofluorescence signal was detected by the Odyssey infrared imaging system (LICOR Biosciences, Lincoln, Neb, USA).
Analysis of morphology and cell proliferation in rat carotid arteries
Rats were sacrificed and perfused with a 4% paraformaldehyde solution in PBS. The carotid arteries were immediately divided into two sections from the middle portion of the balloon-injured segment. Briefly, cryosections (7 μm thickness, 350 μm apart) were taken, and eight slices of each sample were analyzed by hematoxylin & eosin staining and Spot Image software (Diagnostic Instruments, Australia). To measure cell replication in vivo, frozen sections were incubated with anti-PCNA antibodies (1:50, Santa Cruz, CA, USA), horseradish peroxidase-conjugated goat anti-rabbit IgG and 3, 3-diaminobenzidine successively. Sections were then counterstained with hematoxylin.
VSMC proliferation assay
For [ 3 H]-thymidine incorporation assay, DNA synthesis in VSMCs with and without appropriate treatments was measured by pulse-labeling cells for the last 6 h of the 48 h treatment period with 1 μCi mL 1 [ 3 H]-thymidine. The reaction was terminated by three washes of ice-cold PBS and the radioactivity was assessed by scintillation counter (Beckman, USA). For protein determination, cells were washed gently with PBS, and protein contents were measured using a BCA protein assay kit (Pierce, Rockford, IL, USA). For the cell counting assay, VSMCs were trypsinized to single-cell suspension, and 3,000 cells were transferred to each well of a 96-well plate. Cell Counting Kit-8 (CCK-8) reagent was added 48 h after treatment and incubated at 37°C for 24 h according to the color change. The A (optical density) value at 450 nm was read by a microplate reader (Varioskan Flash, Thermo Fisher, USA).
Statistical analysis
All continuous data are presented as mean±standard error of the mean (SEM). Protein band density was normalized to the corresponding loading control and then to the mean of the corresponding control group. Paired t-test (two sided) was applied to analyze the effect of ADAMTS-7 overexpression or knockdown on proliferation in VSMCs. Unpaired t-test (two sided) was performed in comparing PCNA positive cells in injured arteries among groups. One way ANOVA was applied to examine the effect of siRNA ADAMTS-7 on ADAMTS-7 silencing in injured arteries, followed by Student-Newman-Keuls test for post hoc comparison as appropriate. All statistical analysis was performed by GraphPad Prism5.0 (GraphPad Software Inc, San Diego, CA, USA). A P<0.05 was considered statistically significant.
Results
ADAMTS-7 overexpression promotes neointima formation and VSMC proliferation in injured arteries
To investigate the effect of ADAMTS-7 on VSMC proliferation in vivo, we first applied adenovirus to overexpress ADAMTS-7 (Ad-ADAMTS-7) in rat balloon-injured carotid arteries. As shown in Figure 1A , successful infection was evidenced by Western blot analysis 4 d after injury. While ADAMTS-7 was overexpressed, neointima size was markedly increased compared with Ad-GFP infected groups 7 d after balloon injury ( Figure 1B) . In accordance, immunohistochemical staining against proliferating cell nuclear antigen (PCNA) revealed enhanced proliferation of VSMCs in both intima and media of injured arteries 7 d after injury ( Figure 1C ). The PCNA-positive cells of intima were 2-fold greater in Ad-ADAMTS-7 infected than in Ad-GFP infected vessels (ADAMTS-7 vs. GFP: 47.5%±1.6% vs. 23.4%± 0.9%) and 1.4-fold higher in media (ADAMTS-7 vs. GFP: 10.9%±0.8% vs. 7.7%±1.0%), respectively ( Figure 1D and E). 
ADAMTS-7 knockdown reduces neointimal thickening and VSMCs replication in response to artery injury
Next we asked whether ADAMTS-7 knockdown reciprocally could suppress VSMCs replication in vivo. Successful ADAMTS-7 silencing was achieved through perivascular application of specific siRNA mixed with pluronic gel (Figure 2A) . In extraction from 7-day post-injured arteries, siRNA ADAMTS-7 reduced carotid artery expression of ADAMTS-7 protein to levels comparable to those of un-injured rats (Figure 2A, n=46, P<0 .05). Consistent with this observation, there was a robust decrease of neointima area in siRNA ADAMTS-7 treated rats compared to siRNA scramble administration ( Figure 2B ). Consistently, PCNA positive cells in the intima of arteries with siRNA ADAMTS-7 knockdown were significantly less than that of siRNA scramble knockdown (26.1%±3.3% vs. 38.1%±2.4%) (Figure 2C and D). In contrast, there was no difference of PCNA positive cells in the media between the two groups (8.0%±0.7% vs. 7.8%±0.6%) ( Figure 2E ).
ADAMTS-7 enhances proliferation of VSMCs in vitro
To exclude the possibility that the effect of ADAMTS-7 on VSMC proliferation in injured arteries are secondary to promotion of migration by ADAMTS-7, we further examined the effect of ADAMTS-7 on VSMC proliferation in primary isolated VSMCs. As shown in Figure 3A , infection of VSMCs with Ad-ADAMTS-7 at 10 multiplicities of infection (MOI) markedly increased ADAMTS-7 protein level compared to Ad-GFP-infected VSMCs. Therefore, we used 10 MOI of adenovirus in subsequent studies. [ 3 H]-thymidine incorporation assay revealed enhanced proliferation (by 61%) of Ad-ADAMTS-7-infected VSMCs compared to Ad-GFP-infected cells ( Figure 3B ). Moreover, protein quantification assay was performed to monitor the VSMCs replication rate. As shown in Figure 3C , total protein concentration was 1.5-fold increase in Ad-ADAMTS-7 infected cells compared with Ad-GFP infected cells 3 d after infection. Consistently, an increase in proliferation was observed in VSMCs overexpressing ADAMTS-7 compared to the control, according to CCK-8 analysis ( Figure 3D ). Taken together, these data reinforce our hypothesis that ADAMTS-7 overexpression promotes VSMC proliferation.
ADSMTS-7 silencing by siRNA ameliorates VSMCs proliferation
Motivated by the observation that enforced expression of ADAMTS-7 facilitates VSMC proliferation in vitro, we suspected that endogenous ADAMTS-7 played a key role in VSMC proliferation. To test our hypothesis, specific siRNA was applied to silence ADAMTS-7. Knockdown of ADAMTS-7 in VSMCs was verified by Western blot analysis ( Figure 4A ). In agreement with in vivo study, data from [ 3 H]-thymidine incorporation assay showed that ADAMTS-7 knockdown retarded VSMCs proliferation by 23% compared with siRNA scramble ( Figure 4B ). In addition, PCNA 3 H]-thymidine incorporation assay of VSMCs. VSMCs were treated with adenovirus followed by serum-starving for 24 h, and subjected to PDGF-BB (25 ng mL 1 ) treatment for 48 h with the addition of [ 3 H]-thymidine (1 μCi mL 1 ). Results are expressed as mean±SEM CPM from three independent experiments performed in duplicate; *, P<0.05 vs. Ad-GFP. C, Cell protein assay. VSMCs were treated with adenovirus followed by serum-starving for 24 h, and subjected to PDGF-BB (25 ng mL 1 ) for 3 d, then whole cell lysates were harvested and the concentration was tested by BCA protein assay kit. positive cells revealed by PCNA staining in primary VSMCs was also decreased in ADAMTS-7 knockdown groups compared to scrambled groups ( Figure 4C ). CCK-8 assay revealed a reduced proliferation in siRNA ADAMTS-7 -treated VSMCs compared with siRNA scramble -treated ones ( Figure 4D ). Taking together, our data indicates an effect of endogenous ADAMTS-7 on VSMCs proliferation in vitro.
COMP has no effect on VSMC proliferation
Our previous studies have shown that ADAMTS-7 directly binds to and degrades COMP in VSMCs and injured vessels and subsequently promotes VSMC migration [9,10]. Since COMP is the solely identified substrate of ADAMTS-7, we then examined whether COMP also affected VSMC proliferation. Interestingly, COMP overexpression had no effect on VSMC proliferation in [ 3 H]-thymidine incorporation assay ( Figure 5A ). Furthermore, silence of endogenous COMP in VSMCs did not affect cell proliferation in CCK-8 assay ( Figure 5B) . Moreover, overexpression of COMP exhibited no effect on the aggravated proliferation by excessive ADAMTS-7 ( Figure 5C ). Thus, other substrate of ADAMTS-7 but not COMP may mediate its effect on VSMCs migration.
Discussion
We have recently demonstrated that ADAMTS-7 plays a Figure 5 COMP had no effect on VSMCs proliferation. A, VSMCs were treated with adenovirus followed by serum-starving for 24 h, and subjected to PDGF-BB (25 ng mL 1 ) or culture alone for 48 h with the addition of [ 3 H]-thymidine (1 μCi mL 1 ). The reaction was terminated by three washes of ice-cold PBS and the radioactivity was assessed by scintillation counter. Results are expressed as mean±SEM fold of Ad-GFP from three independent experiments performed in duplicate; *, P<0.05. B, Proliferation of VSMCs transfected with siRNA scramble or siRNA COMP was determined by CCK-8. VSMCs were treated with siRNA followed by serum-starving, and subjected to PDGF-BB (25 ng mL 1 ) or culture alone for another 48 h. Results are mean±SEM from three independent experiments performed in duplicate; *, P<0.05. C, Recruitment of COMP did not effect ADAMTS-7-facilitated VSMC proliferation. VSMC were co-infected with both Ad-ADAMTS-7 and Ad-COMP and analyzed by CCK-8. Results are mean±SEM from three independent experiments performed in duplicate; *, P<0.05. NS, not significant. pivotal role in neointima formation in response to injury by promoting VSMC migration in vitro and in vivo [10] . In the current study, we further advanced our knowledge by demonstrating that ADAMTS-7 facilitates VSMC proliferation and subsequent intima hyperplasia. ADAMTS-7 may therefore act as a promising target for prevention and treatment of vascular proliferative diseases including atherosclerosis, post-angioplasty restenosis, vein graft disease and transplant vasculopathy.
Unlike other metalloproteinases, ADAMTS members exhibit narrow substrate specificity due to the existence of various C-terminal thrombospondin motif, which makes them potentially safe pharmaceutical targets [18] . The ADAMTS family has been implicated in various diseases such as cancer, arthritis and atherosclerosis. For example, ADAMTS-1 has anti-angiogenic activities [19] and is crucial for tumor progression [20] . ADAMTS-4 and ADAMTS-5 are important mediators of arthritis [2123] . ADAMTS-13 is a von Willebrand factor-cleaving protease, and its mutations lead to inherited life-threatening thrombocytopenic purpura [24] . Recently, the role of ADAMTS proteases in inflammation and atherosclerosis has come to light [25] . Jonsson-Rylander and colleagues [26] reported that ADAMTS-1 might expedite atherogenesis by cleaving the ECM protein versican. The 227
Pro polymorphism in ADAMTS-1 was associated with a nearly twofold increased risk of coronary heart disease event [27] . ADAMTS-4 and -8 were also identified as inflammatory-regulated enzymes in macrophage-rich areas of human atherosclerotic plaques [28] . ADAMTS-5 can reduce the LDL binding ability of biglycan and released LDL from human aortic lesions, indicating its important role in regulating proteoglycan turnover and lipoprotein retention in atherosclerosis [29] . However, the relevance of ADAMTS family members to cardiovascular disease remains largely unknown. The ADAMTS7 locus was recently identified to have a strong association with coronary atherosclerotic disease [15, 16] . We are the first to reveal the relevance of ADAMTS-7 on neointima formation via affecting both VSMCs migration [10] and proliferation. However, the underlying mechanism is not yet understood. The importance of ADAMTS-7 in cardiovascular disease needs to be further explored.
Excessive proliferation of VSMCs in response to injury has been related to activation of a variety of growth factors and cytokine such as basic fibroblast growth factor (bFGF) [30] , platelet-derived growth factor (PDGF) [31] , transforming growth factor-β (TGF-β) [32] , angiotensin II [33] , and/or insulin like growth factor-1 (IGF) [34] . Growth factors and cytokines share a final proliferative signaling pathway, namely the cell cycle [35] . Cell cycle progression involves subtle tune of cyclins/cyclin dependent kinases (CDKs) and cyclin dependent kinase inhibitors (CKIs) such as p27 KIP1 and p21 CIP1 [36, 37] . Instead of directly interfering with cell cycle proteins, MMPs have been implicated in VSMC proliferation via indirect effects, such as releasing of matrix-anchored growth factors or ablation of cell-cell contact protein like N-cadherin [8] . Nevertheless, the effect of MMPs on VSMC proliferation in vivo is ambiguous and even controversial to some extent [3841]. One possibility explaining the controversy is that metalloproteinases other than MMPs may contribute more to activating VSMC proliferation in vivo. In the current study, we demonstrated for the first time that ADAMTS-7 accelerated VSMC proliferation both in vitro and in vivo. However, the underlying mechanism is still elusive. Previously we have shown that ADAMTS-7 degrades matrix protein COMP in vessels [10] . COMP constrains VSMCs migration via maintaining VSMCs in a quiescent/contractile phenotype [11] . COMP itself interacts with BMP-2 and prevents VSMC transdifferentiation into an osteogenic phenotype [13] . Thus, ADAMTS-7 promotes neointima formation and vascular calcification via degradation of COMP [10, 12] . It is thereby highly conceivable that ADAMTS-7 facilitates VSMCs replication through degradation of COMP. However, COMP manipulation by adenovirus does not affect VSMC proliferation in vitro. Hence it seems unlikely that ADAMTS-7 promotes VSMC proliferation via interfering with COMP. Further proteomics analysis is needed to identify a novel substrate of ADAMTS-7 and reveal the mechanism attributable to ADAMTS-7 mediated VSMC proliferation.
In summary, our studies illustrate pro-proliferative effects of ADAMTS-7 on VSMCs both in vitro and in an arterial injury model. These findings offer new insights into the role of ADAMTS-7 in VSMC biological behaviors. Inhibition of ADAMTS-7 not only retards VSMC migration, but also inhibits VSMC proliferation, which suggests ADAMTS-7 to be a potential therapeutic target for proliferative and migratory cardiovascular diseases such as atherosclerosis and restenosis.
